Your browser doesn't support javascript.
loading
Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
Goettel, Markus; Fuertig, Rene; Mack, Salome Rebecca; Just, Stefan; Sharma, Vikas; Wunder, Andreas; den Boer, Johan.
Afiliação
  • Goettel M; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany. markus.goettel@boehringer-ingelheim.com.
  • Fuertig R; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • Mack SR; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • Just S; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • Sharma V; Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany.
  • Wunder A; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400, Biberach an der Riss, Germany.
  • den Boer J; PRA Health Sciences, Groningen, The Netherlands.
CNS Drugs ; 37(12): 1099-1109, 2023 12.
Article em En | MEDLINE | ID: mdl-38019356

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetragastrina / Hidrocortisona Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetragastrina / Hidrocortisona Idioma: En Ano de publicação: 2023 Tipo de documento: Article